Kala Bio (KALA) Return on Sales [ROS] (2019 - 2022)
Kala Bio's Return on Sales [ROS] came in at -2099.33% for Q4 2022, up 423.03 percentage points from -2522.36% a year earlier and up 1369.48 percentage points from the prior quarter.
Powered by 
Analysis
Kala Bio (KALA) Return on Sales [ROS] (2019 - 2022) Analysis & Trends
Going back to Q1 2019, Kala Bio's Return on Sales [ROS] data covers 16 quarters.
- Return on Sales [ROS] carries a three-year change of -646.85 percentage points (FY2019 to FY2022).
- Going back by year, Return on Sales [ROS] was -1158.76% in FY2021 (+353.83 pp), -1512.59% in FY2020 (-60.10 pp) and -1452.49% in FY2019.
- The five-year range for quarterly Return on Sales [ROS] is -3468.81% (Q3 2022) to -850.05% (Q3 2021).
- Year-over-year, Return on Sales [ROS] increased in four of the last eight quarters, with an average year-over-year change of -270.66 percentage points.
- The fastest year-over-year change in Return on Sales [ROS] over five years came in Q2 2021 (a gain of 1602.64 percentage points), and the weakest in Q3 2022 (a drop of 2618.76 percentage points).
- Business Quant data shows KALA's Return on Sales [ROS] at -3468.81% (Q3 2022), -1236.76% (Q2 2022) and -2253.21% (Q1 2022) in the three quarters before Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Kala Bio | 5.81 Mn | 5.81 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -2,099.33% |
| Sep 30, 2022 | -3,468.81% |
| Jun 30, 2022 | -1,236.76% |
| Mar 31, 2022 | -2,253.21% |
| Dec 31, 2021 | -2,522.36% |
| Sep 30, 2021 | -850.05% |
| Jun 30, 2021 | -951.98% |
| Mar 31, 2021 | -866.93% |
| Dec 31, 2020 | -1,295.08% |
| Sep 30, 2020 | -1,164.05% |
| Jun 30, 2020 | -2,554.62% |
| Mar 31, 2020 | -1,879.08% |
| Dec 31, 2019 | -1,711.61% |
| Sep 30, 2019 | -1,486.35% |
| Jun 30, 2019 | -1,089.45% |
| Mar 31, 2019 | -1,735.21% |
API Access
Kala Bio Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=KALA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "KALA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=KALA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();